Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Josef Auernhammer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|December 3, 2019
[The Thyroid and Pregnancy]Viktoria Florentine Koehler, Christoph Josef Auernhammer, Christine Spitzweg
Deutsche Medizinische Wochenschrift (1946)|October 9, 2019
[Current standards and novel developments in the treatment of neuroendocrine tumors of the gastroenteropancreatic system]Christoph Josef Auernhammer, Christine Spitzweg, Stefan Böck, et al.
Cancers|April 3, 2021
Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In VitroXi-Feng Jin, Gerald Spöttl, Julian Maurer, et al.
Cancers|February 9, 2020
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors in vitro: Antitumoral EffectsXi-Feng Jin, Gerald Spoettl, Julian Maurer, et al.
Neuroendocrinology|February 23, 2017
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitroElke Tatjana Aristizabal Prada, Svenja Nölting, Gerald Spoettl, et al.
The Journal of Pathology. Clinical Research|November 16, 2020
Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entityChristine Woischke, Peter Jung, Andreas Jung, et al.
Neuroendocrinology|October 3, 2017
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine TumorsElke Tatjana Aristizabal Prada, Carla Weis, Michael Orth, et al.
Cancers|April 3, 2021
Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver TumorsPaul Rogowski, Rieke von Bestenbostel, Franziska Walter, et al.
Diagnostic and Interventional Imaging|July 15, 2023
Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CTMaria Ingenerf, Freba Grawe, Michael Winkelmann, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 19, 2022
Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysisSimon Sirtl, Ujjwal M Mahajan, Christoph Josef Auernhammer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|December 3, 2019
[The Thyroid and Pregnancy]Viktoria Florentine Koehler, Christoph Josef Auernhammer, Christine Spitzweg
Deutsche Medizinische Wochenschrift (1946)|October 9, 2019
[Current standards and novel developments in the treatment of neuroendocrine tumors of the gastroenteropancreatic system]Christoph Josef Auernhammer, Christine Spitzweg, Stefan Böck, et al.
Cancers|April 3, 2021
Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In VitroXi-Feng Jin, Gerald Spöttl, Julian Maurer, et al.
Cancers|February 9, 2020
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors in vitro: Antitumoral EffectsXi-Feng Jin, Gerald Spoettl, Julian Maurer, et al.
Neuroendocrinology|February 23, 2017
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitroElke Tatjana Aristizabal Prada, Svenja Nölting, Gerald Spoettl, et al.
The Journal of Pathology. Clinical Research|November 16, 2020
Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entityChristine Woischke, Peter Jung, Andreas Jung, et al.
Neuroendocrinology|October 3, 2017
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine TumorsElke Tatjana Aristizabal Prada, Carla Weis, Michael Orth, et al.
Cancers|April 3, 2021
Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver TumorsPaul Rogowski, Rieke von Bestenbostel, Franziska Walter, et al.
Diagnostic and Interventional Imaging|July 15, 2023
Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CTMaria Ingenerf, Freba Grawe, Michael Winkelmann, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 19, 2022
Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysisSimon Sirtl, Ujjwal M Mahajan, Christoph Josef Auernhammer, et al.
Pageof 2